Epipharyngeal Abrasive Therapy (EAT) Has Potential as a Novel Method for Long COVID Treatment

Epipharyngeal Abrasive Therapy (EAT) Has Potential as a Novel Method for Long COVID Treatment

COVID-19 often causes sequelae after initial recovery, referred to collectively as long COVID. Long COVID is considered to be caused by the persistence of chronic inflammation after acute COVID-19 infection. We found that all long COVID patients had residual inflammation in the epipharynx, an import...

Full description

Bibliographic Details
Main Authors: Kazuaki Imai, Takafumi Yamano, Soichiro Nishi, Ryushiro Nishi, Tatsuro Nishi, Hiroaki Tanaka, Toshiyuki Tsunoda, Shohei Yoshimoto, Ayaki Tanaka, Kenji Hiromatsu, Senji Shirasawa, Takashi Nakagawa, Kensuke Nishi
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Viruses
Subjects:
long COVID
epipharyngeal abrasive therapy (EAT)
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
chronic epipharyngitis
Online Access:https://www.mdpi.com/1999-4915/14/5/907

Internet

https://www.mdpi.com/1999-4915/14/5/907

Similar Items